Bremelanotide PT 141     189691-06-3    professional supplier

Specification:

Bremelanotide  // PT141

Cas 189691-06-3   

MF C50H68N14O10 

MW 1025.2 g/mol

Absrtact Bremelanotide (formerly PT-141) is a compound under drug development by Palatin Technologies as a treatment for female sexual dysfunction, hemorrhagic shock and reperfusion injury. It functions by activating the melanocortin receptors MC1R and MC4R, to modulate inflammation and limitingischemia. It was originally tested for intranasal administration in treating female sexual dysfunctionbut this application was temporarily discontinued in 2008 after concerns were raised over adverse side effects of increased blood pressure. As of March, 2012, Palatin is conducting a human Phase 2B study using a new subcutaneous drug delivery system that appears to have little effect on blood pressure.

Payment:

We recommend T/T or Escrow , D/P,D/A, or PayPal are also acceptable!

 

 

Delivery:

 

In about 3 working days after the receipt of payment, we will follow up the delivery until you receive it.  

 

Express way as the following is:

(Shipping : TNT,Fedex,DHL,USP,EMS and so on)

 

 

 

Packaging: 

 Drum&plastic bags, Aluminum foiled bag,Zip lock bags   

 

 

Laboratory:

 

 

 

Our Company:

 

Our company advantage:

1.Small order is acceptable

 

2.Can provide sample for you

 

3.Have self-export rights

 

 

 

 

Exhibition:

 

 

 

  Certification:

 

 

 

 

 

The End